Abstract
VAP proteins are a small family of type II membrane proteins enriched on the endoplasmic reticulum that have been conserved from yeast to mammals. The N-terminal half of the proteins consists of a domain highly homologous to a polypeptide found in the motile sperm of nematodes known as the major sperm protein (MSP). A mis-sense mutation in human vapB that changes a proline residue to a serine in the most highly conserved region of the MSP domain causes a rare form of motor neuron disease, amyotrophic lateral sclerosis type 8. Whether vapB P56S is a gain or loss of function mutation is not yet clear, however, it causes the protein to aggregate and may disrupt the normal function and regulation of the ER.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abe, K., M. Aoki, et al. (1996). “Clinical characteristics of familial amyotrophic lateral sclerosis with Cu/Zn superoxide dismutase gene mutations.” J Neurol Sci 136(1–2): 108–16.
Amarilio, R., S. Ramachandran, et al. (2005). “Differential regulation of endoplasmic reticulum structure through VAP-Nir protein interaction.” J Biol Chem 280(7): 5934–44.
Andersen, P. M. (2006). “Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene.” Curr Neurol Neurosci Rep 6(1): 37–46.
Arrasate, M., S. Mitra, et al. (2004). “Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death.” Nature 431(7010): 805–10.
Atkin, J. D., M. A. Farg, et al. (2006). “Induction of the unfolded protein response in familial amyotrophic lateral sclerosis and association of protein disulfide isomerase with superoxide dismutase 1.” J Biol Chem 281: 30152–65.
Bernales, S., F. R. Papa, et al. (2006). “Intracellular signaling by the unfolded protein response.” Annu Rev Cell Dev Biol 22(1): 487–508.
Brickner, J. H. and P. Walter (2004). “Gene recruitment of the activated INO1 locus to the nuclear membrane.” PLoS Biol 2(11): e342.
Chai, A., J. Withers, et al. (2008). “hVAPB, the causative gene of a heterogeneous group of motor neuron diseases in humans, is functionally interchangeable with its Drosophila homologue DVAP-33A at the neuromuscular junction.” Hum Mol Genet 17(2): 266–80.
Chang, H. J., S. A. Jesch, et al. (2004). “Role of the unfolded protein response pathway in secretory stress and regulation of INO1 expression in Saccharomyces cerevisiae.” Genetics 168(4): 1899–913.
Dominic M., D. J. S. Walsh (2007). “Aβ Oligomers – a decade of discovery.” J Neurochem 101(5): 1172–84.
Edwards, D. R., M. M. Handsley, et al. (2008). “The ADAM metalloproteinases.” Mol Aspects Med 29(5): 258–89.
Foster, L., M. Weir, et al. (2000). “A functional role for VAP-33 in insulin-stimulated GLUT4 traffic.” Traffic 1(6): 512–21.
Gao, L., H. Aizaki, et al. (2004). “Interactions between viral nonstructural proteins and host protein hVAP-33.” J Virol 78(7): 3480–8.
Gkogkas, C., S. Middleton, et al. (2008). “VAPB interacts with and modulates the activity of ATF6.” Hum Mol Genet 17: 1517–26.
Haass, C. and D. J. Selkoe (2007). “Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid beta-peptide.” Nat Rev Mol Cell Biol 8(2): 101–12.
Hamamoto, I., Y. Nishimura, et al. (2005). “Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B.” J Virol 79(21): 13473–82.
Hand, C. and G. Rouleau (2002). “Familial amyotrophic lateral sclerosis.” Muscle Nerve 25(2): 135–59.
Ito, K., T. Uchiyama, et al. (2002). “[Different clinical phenotypes of siblings with familial amyotrophic lateral sclerosis showing Cys146Arg point mutation of superoxide dismutase 1 gene].” Rinsho Shinkeigaku 42(2): 175–7.
Kaiser, S. E., J. H. Brickner, et al. (2005). “Structural basis of FFAT motif-mediated ER targeting.” Structure 13(7): 1035–45.
Kanekura, K., I. Nishimoto, et al. (2006). “Characterization of amyotrophic lateral sclerosis-linked P56S mutation of vesicle-associated membrane protein-associated protein B (VAPB/ALS8).” J Biol Chem 281(40): 30223–33.
Katayama, T., K. Imaizumi, et al. (2001). “Disturbed activation of endoplasmic reticulum stress transducers by familial Alzheimer’s disease-linked Presenilin-1 mutations.” J Biol Chem 276(46): 43446–54.
Kawano, M., K. Kumagai, et al. (2006). “Efficient trafficking of ceramide from the endoplasmic reticulum to the Golgi apparatus requires a VAMP-associated protein-interacting FFAT motif of CERT.” J Biol Chem 281(40): 30279–88.
King, K. L., M. Stewart, et al. (1992). “Structure and macromolecular assembly of two isoforms of the major sperm protein (MSP) from the amoeboid sperm of the nematode, Ascaris suum.” J Cell Sci 101(4): 847–857.
Klein, R. (2009). “Bidirectional modulation of synaptic functions by Eph/ephrin signaling.” Nat Neurosci 12(1): 15–20.
Lapierre, L., P. Tuma, et al. (1999). “VAP-33 localizes to both an intracellular vesicle population and with.” J Cell Sci 112(Pt 21): 3723–32.
Loewen, C., A. Roy, et al. (2003). “A conserved ER targeting motif in three families of lipid binding proteins.” EMBO J 22(9): 2025–35.
Loewen, C. J. and T. P. Levine (2005). “A highly conserved binding site in vesicle-associated membrane protein-associated protein (VAP) for the FFAT motif of lipid-binding proteins.” J Biol Chem 280(14): 14097–104.
Marciniak, S. J. and D. Ron (2006). “Endoplasmic reticulum stress signaling in disease.” Physiol Rev 86(4): 1133–49.
Marques, V. D., A. A. Barreira, et al. (2006). “Expanding the phenotypes of the Pro56Ser VAPB mutation: proximal SMA with dysautonomia.” Muscle Nerve 34(6): 731–9.
Menzies, F., A. Grierson, et al. (2002). “Selective loss of neurofilament expression in Cu/Zn superoxide dismutase.” J Neurochem 82(5): 1118–28.
Nikawa, J.-I., A. Murakami, et al. (1995). “Cloning and sequence of the SCS2 gene, which can suppress the defect of IN01 expression in an inositol auxotrophic mutant of Saccharomyces cerevisiae.” J Biochem 118(1): 39–45.
Nishimura, A., M. Mitne-Neto, et al. (2004a). “A novel locus for late onset amyotrophic lateral sclerosis/motor neurone.” J Med Genet 41(4): 315–20.
Nishimura, A. L., M. Mitne-Neto, et al. (2004b). “A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis.” Am J Hum Genet 75(5): 822–31.
Nishimura, Y., M. Hayashi, et al. (1999). “Molecular cloning and characterization of mammalian homologues of vesicle-associated membrane protein-associated (VAMP-associated) proteins.” Biochem Biophys Res Commun 254(1): 21–26.
Pennetta, G., P. Hiesinger, et al. (2002). “Drosophila VAP-33A directs bouton formation at neuromuscular junctions in a dosage dependent manner.” Neuron 35(2): 291–306.
Prosser, D. C., D. Tran, et al. (2008). “FFAT rescues VAPA-mediated inhibition of ER-to-Golgi transport and VAPB-mediated ER aggregation.” J Cell Sci 121(18): 3052–61.
Ratnaparkhi, A., G. M. Lawless, et al. (2008). “A Drosophila model of ALS: human ALS-associated mutation in VAP33A suggests a dominant negative mechanism.” PLoS ONE 3(6): e2334.
Rosen, D. R., T. Siddique, et al. (1993). “Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.” Nature 362: 59–62.
Schroder, M. and R. J. Kaufman (2005). “The mammalian unfolded protein response.” Annu Rev Biochem 74: 739–89.
Schymick, J. C., K. Talbot, et al. (2007). “Genetics of sporadic amyotrophic lateral sclerosis.” Hum Mol Genet 16(R2): R233–242.
Sepsenwol, S., H. Ris, et al. (1989). “A unique cytoskeleton associated with crawling in the amoeboid sperm of the nematode, Ascaris suum.” J Cell Biol 108(1): 55–66.
Shen, J., X. Chen, et al. (2002). “ER stress regulation of ATF6 localization by dissociation of BiP/GRP78 binding and unmasking of Golgi localization signals.” Dev Cell 3(1): 99–111.
Simon, A. M., R. L. de Maturana, et al. (2009). “Early changes in hippocampal Eph receptors precede the onset of memory decline in mouse models of Alzheimer’s disease.” J Alzheimers Dis 17: 773–86.
Skehel, P., R. Fabian-Fine, et al. (2000). “Mouse VAP33 is associated with the endoplasmic reticulum and microtubules.” Proc Natl Acad Sci U S A 97(3): 1101–6.
Skehel, P., K. Martin, et al. (1995). “A VAMP-binding protein from Aplysia required for neurotransmitter release.” Science 269(5230): 1580–3.
Snapp, E. L., R. S. Hegde, et al. (2003). “Formation of stacked ER cisternae by low affinity protein interactions.” J Cell Biol 163(2): 257–69.
Soto, C. (2003). “Unfolding the role of protein misfolding in neurodegenerative diseases.” Nat Rev Neurosci 4(1): 49–60.
Soussan, L., D. Burakov, et al. (1999). “ERG30, a VAP-33-related protein, functions in protein transport mediated.” J Cell Biol 146(2): 301–11.
Talbot, K. (2002). “Motor neurone disease.” Postgrad Med J 78(923): 513–519.
Tardif, K. D., K. Mori, et al. (2004). “Hepatitis C virus suppresses the IRE1-XBP1 pathway of the unfolded protein response.” J Biol Chem 279(17): 17158–64.
Teuling, E., S. Ahmed, et al. (2007). “Motor neuron disease-associated mutant vesicle-associated membrane protein-associated protein (VAP) B recruits wild-type VAPs into endoplasmic reticulum-derived tubular aggregates.” J Neurosci 27(36): 9801–15.
Tomita, T., S. Tanaka, et al. (2006). “Presenilin-dependent intramembrane cleavage of ephrin-B1.” Mol Neurodegener 1: 2.
Tompkins, M. M. and W. D. Hill (1997). “Contribution of somal Lewy bodies to neuronal death.” Brain Res 775(1–2): 24–9.
Tsuda, H., S. M. Han, et al. (2008). “The amyotrophic lateral sclerosis 8 protein VAPB is cleaved, secreted, and acts as a ligand for Eph receptors.” Cell 133(6): 963–977.
Tu, H., L. Gao, et al. (1999). “Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like.” Virology 263(1): 30–41.
Wang, Y., J. Shen, et al. (2000). “Activation of ATF6 and an ATF6 DNA binding site by the endoplasmic reticulum stress response.” J Biol Chem 275(35): 27013–20.
Weir, M., A. Klip, et al. (1998). “Identification of a human homologue of the vesicle-associated membrane.” Biochem J 333(Pt 2): 247–51.
Welsem, M. v., J. Hogenhuis, et al. (2002). “The relationship between Bunina bodies, skein-like inclusions and neuronal.” Acta Neuropathol 103(6): 583–9.
Williamson, T., L. Corson, et al. (2000). “Toxicity of ALS-linked SOD1 mutants.” Science 288(5465): 399.
Wyles, J. P., C. R. McMaster, et al. (2002). “Vesicle-associated membrane protein-associated protein-A (VAP-A) interacts with the oxysterol-binding protein to modify export from the endoplasmic reticulum.” J. Biol. Chem. 277(33): 29908–18.
Ye, J., R. B. Rawson, et al. (2000). “ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs.” Mol Cell 6(6): 1355–64.
Yoshida, H., K. Haze, et al. (1998). “Identification of the cis-acting endoplasmic reticulum stress response element responsible for transcriptional induction of mammalian glucose-regulated proteins. Involvement of basic leucine zipper transcription factors.” J Biol Chem 273(50): 33741–9.
Zhang, K. and R. J. Kaufman (2005). “The unfolded protein response. A stress signaling pathway critical for health and disease.” Neurology 2006 66(2 Suppl 1): S102–9.
Zheng, Y., B. Gao, et al. (2005). “Hepatitis C virus non-structural protein NS4B can modulate an unfolded protein response.” J Microbiol 43(6): 529–36.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Skehel, P. (2011). VAPB Aggregates and Neurodegeneration. In: Wyttenbach, A., O'Connor, V. (eds) Folding for the Synapse. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-7061-9_11
Download citation
DOI: https://doi.org/10.1007/978-1-4419-7061-9_11
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-7060-2
Online ISBN: 978-1-4419-7061-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)